Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Serious adverse event caused by combined target therapy (CROSBI ID 68001)

Prilog u knjizi | stručni rad

Poduje, Sanja ; Marić Brozić, Jasmina ; Prkačin, Ivana ; Delaš Aždajić, Marija ; Goren, Andy Serious adverse event caused by combined target therapy // Clinical cases in melanoma / Lotti, Torello ; Tirant, Michael ; Wollina, Uwe (ur.). Cham: Springer, 2020. str. 5-8 doi: 10.1007/978-3-030-50820-3

Podaci o odgovornosti

Poduje, Sanja ; Marić Brozić, Jasmina ; Prkačin, Ivana ; Delaš Aždajić, Marija ; Goren, Andy

engleski

Serious adverse event caused by combined target therapy

Combined target therapy commonly causes mild to moderate adverse events on the skin (such as rash, hyperkeratosis and photosensitivity reaction). Serious adverse events such as Stevens-Johnson syndrome and toxic epidermal necrolysis induced by combined therapy are rare, but life-threating conditions and should be recognized and treated on time.

combined target therapy ; toxic epidermal necrolysis ; metastatic melanoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

5-8.

objavljeno

10.1007/978-3-030-50820-3

Podaci o knjizi

Clinical cases in melanoma

Lotti, Torello ; Tirant, Michael ; Wollina, Uwe

Cham: Springer

2020.

978-3-030-50819-7

2730-6178

Povezanost rada

Kliničke medicinske znanosti

Poveznice